Kliegel Andreas, Losert Heidrun, Sterz Fritz, Kliegel Matthias, Holzer Michael, Uray Thomas, Domanovits Hans
Department of Emergency Medicine, Medical University Vienna, 1090 Wien, Austria.
Resuscitation. 2005 Mar;64(3):347-51. doi: 10.1016/j.resuscitation.2004.09.002.
Mild therapeutic hypothermia has shown to improve neurological outcome after cardiac arrest. Our study investigated the efficacy and safety of cold simple intravenous infusions for induction of hypothermia after cardiac arrest preceding further cooling and maintenance of hypothermia by specialised endovascular cooling.
All patients admitted after cardiac arrest of presumed cardiac aetiology were screened. Patients enrolled received 2000 ml of ice-cold (4 degrees C) fluids via peripheral venous catheters. As soon as possible endovascular cooling was applied even if the cold infusions were not completed. The target temperature was defined as 33 +/- 1 degrees C. All temperatures recorded were measured via bladder-temperature probes. The primary endpoint was the time from return of spontaneous circulation to reaching the target temperature. Secondary endpoints were changes in haemodynamic variables, oxygenation, haemoglobin, clotting variables and neurological outcome.
Out of 167 screened patients 26 (15%) were included. With a total amount of 24 +/- 7 ml/kg cold fluid at 4 degrees C the temperature could be lowered from 35.6 +/- 1.3 degrees C on admission to 33.8 +/- 1.1 degrees C. The target temperature was reached 185 +/- 119 min after return of spontaneous circulation, 135 +/- 112 min after start of infusion, and 83 +/- 85 min after start of endovascular cooling. Except for two patients showing radiographic signs of mild pulmonary edema no complications attributable to the infusions could be observed. Thirteen patients (50%) survived with favourable neurological outcome.
Our results indicate that induction of mild hypothermia with infusion of cold fluids preceding endovascular cooling is safe and effective.
轻度治疗性低温已被证明可改善心脏骤停后的神经功能结局。我们的研究调查了在通过专门的血管内冷却进一步降温并维持低温之前,单纯静脉输注冷液体诱导心脏骤停后低温的有效性和安全性。
对所有因推测为心脏病因导致心脏骤停后入院的患者进行筛查。入选患者通过外周静脉导管接受2000毫升冰冷(4摄氏度)液体。即使冷输注未完成,也尽快应用血管内冷却。目标温度定义为33±1摄氏度。所有记录的温度均通过膀胱温度探头测量。主要终点是从自主循环恢复到达到目标温度的时间。次要终点是血流动力学变量、氧合、血红蛋白、凝血变量和神经功能结局的变化。
在167例筛查患者中,26例(15%)被纳入。使用总量为24±7毫升/千克的4摄氏度冷液体,温度可从入院时的35.6±1.3摄氏度降至33.8±1.1摄氏度。在自主循环恢复后185±119分钟、输注开始后135±112分钟以及血管内冷却开始后83±85分钟达到目标温度。除两名患者出现轻度肺水肿的影像学征象外,未观察到与输注相关的并发症。13例患者(50%)存活且神经功能结局良好。
我们的结果表明,在血管内冷却之前通过输注冷液体诱导轻度低温是安全有效的。